Company / PP&E (Net)
GERON CORP PP&E (Net) History
FY2015-FY2024 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest PP&E (Net)
$1.3M
FY2024
5-year range
$650.0K / $1.3M
FY2020-FY2024
Trend
+11.3%
vs FY2023
Sector context
#148 of 193
Health Care
What the data says
GERON CORP's pp&e (net) of $1M is lower than 77% of companies in the Health Care sector (FY2024). PP&E (Net) has increased for 3 consecutive years, from $650,000 in FY2021 to $1M in FY2024.
Based on SEC 10-K filings.
$1M in FY2024 with a 5-year CAGR of +26.3%.
Improved from $793,000 to $1M over the past 2 years.
Health Care sector context is included.
PP&E (Net) over time
Growth rates
- 3-Year CAGR
- +26.3%
- 5-Year CAGR
- +26.3%
- 10-Year CAGR
- -
Sector benchmark
Bottom 23% in Health CareTop 77% of 193This company $1.3M Sector average $777.6M
▼
-99.8% below sector average
Key checks
Key Insights
- GERON CORP's pp&e (net) has grown for 3 consecutive years.
- 5-year CAGR of +26.3%, indicating consistent growth.
- In FY2024, pp&e (net) increased 11.3% year-over-year.
- Ranks #148 out of 193 companies in the Health Care sector.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score -0.05 (distress zone, below 1.8 threshold)
- Low earnings quality (accrual-heavy earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | PP&E (Net)Value | YoY GrowthYoY |
|---|---|---|
| FY2024 | $1.3M | +11.3% |
| FY2023 | $1.2M | +48.4% |
| FY2022 | $793.0K | +22.0% |
| FY2021 | $650.0K | -1.2% |
| FY2020 | $658.0K | +61.3% |
| FY2019 | $408.0K | +591.5% |
| FY2018 | $59.0K | -42.2% |
| FY2017 | $102.0K | -44.3% |
| FY2016 | $183.0K | -11.6% |
| FY2015 | $207.0K | +19.7% |
As of FY2024 · SEC 10-K · Updated Jun 30, 2026